AVEO Pharmaceuticals (AVEO) Posts Narrower than Expected Q2 Loss; Maintains Outlook
Tweet Send to a Friend
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q2 EPS of ($0.68), $0.21 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
